<div class="container">

<table style="width: 100%;"><tr>
<td>actg036</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>AIDS Clinical Trial ACTG036</h2>

<h3>Description</h3>

<p>A data set from the AIDS clinical trial ACTG036 (<a href="https://clinicaltrials.gov/study/NCT00001104">https://clinicaltrials.gov/study/NCT00001104</a>) comparing
zidovudine (AZT) with a placebo in patients with hereditary coagulation disorders and HIV infection. The study
results were described in Merigan et al. (1991) <a href="doi:10.1182/blood.V78.4.900.900">doi:10.1182/blood.V78.4.900.900</a>. This data set has the same
variables as the actg019 data set. We can use the actg019 data as the historical data and the actg036 data as
the current data.
</p>


<h3>Usage</h3>

<pre><code class="language-R">actg036
</code></pre>


<h3>Format</h3>

<p>A data frame with 183 rows and 5 variables:
</p>

<dl>
<dt>outcome</dt>
<dd>
<p>outcome variable with 1 indicating death, development of AIDS or AIDS-related complex (ARC) and 0 otherwise</p>
</dd>
<dt>age</dt>
<dd>
<p>patient age in years</p>
</dd>
<dt>treatment</dt>
<dd>
<p>treatment indicator, 0 = placebo, 1 = AZT</p>
</dd>
<dt>race</dt>
<dd>
<p>race indicator, 0 = non-white, 1 = white</p>
</dd>
<dt>cd4</dt>
<dd>
<p>CD4 cell count</p>
</dd>
</dl>
<h3>References</h3>

<p>Merigan, T., Amato, D., Balsley, J., Power, M., Price, W., Benoit, S., Perez-Michael, A., Brownstein, A., Kramer, A., and Brettler, D. (1991). Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group. Blood, 78(4), 900–906.
</p>
<p>Chen, M.-H., Ibrahim, J. G., and Yiannoutsos, C. (1999). Prior elicitation, Variable Selection and Bayesian computation for Logistic Regression Models. Journal of the Royal Statistical Society Series B: Statistical Methodology, 61(1), 223–242.
</p>


</div>